RESOURCES

NEWS & EVENTS

EWMA 2020

November 2020

Prof. Nikolaos Tentolouris from Laikο General Hospital of Athens, Greece, will present a poster titled “Recombinant human collagen-based flowable matrix for chronic wound managementa case study series”.
EWMA 2020 Virtual

Vergenix™FG now available in Ukraine

October 2020

Patients in Ukraine will now have access to Vergenix™FG.
For more details, contact us

New Vergenix™FG clinical results now published

July 2020

Study by Iacopi E et al from the University Hospital in Pisa, Italy shows increased healing rate and shortened healing time in patients with post-surgical diabetic foot wounds treated with Vergenix™ FG.
Full abstract

MEDICA 2019

November 2019

CollPlant exhibits at the MEDICA trade-fair, 18-21 November 2019, in Düsseldorf, Germany. Visit us at hall 16/ M25.
Medica website

Dr. Eyal Shapira presents Vergenix™FG results and wins the presenter prize at the EWMA 2019

July 2019

Dr. Eyal Shapira from the department of Plastic Surgery, Assaf Harofeh Medical Center, Israel, wins the first time international presenter prize at the EWMA 2019 conference for his oral presentation on the results from a clinical study conducted with Vergenix™FG .
EWMA awards

CollPlant signs a distribution agreement with Green Leaf Pharma

June 2019

CollPlant is pleased to announce that a distribution agreement for Russia and Ukraine has been executed with Green Leaf Pharma, а dynamically growing company specializing in bio-pharmaceutical development and medical device distribution.
Green Leaf Pharma website

Presenting at the EWMA 2019 conference

June 2019

CollPlant to exhibit at the 29th Conference of the European Wound Management Association (EWMA), 5-7 June 2019 in Gothenburg, Sweden. Dr. Eyal Shapira from the department of Plastic Surgery, Assaf Harofeh Medical Center, Israel, to present results from a clinical study conducted with Vergenix™FG. Visit us at booth B09:09.
EWMA 2019 website

Vergenix™FG clinical results published in WOUNDS journal

March 2019

Study published in Wounds Journal shows remarkable wound closure performance with Vergenix™FG in the treatment of chronic wounds with a 94% median wound area reduction.
Full publication

Skip to toolbar